MedAccess

🗞️ The February edition of our Access Matters newsletter is out. This month's highlights include: 🔹What role can industry play in increasing access to medical oxygen? 🔹MedAccess highlights the power and potential of market shaping for health 🔹100 words on... regional vaccine manufacturing Read it here ⬇

Why does market shaping matter? In a healthy market, products are available for patients when they need them at prices they can afford. This means having a range of suppliers in the market providing sufficient volumes and competing to provide high quality products at sustainable prices. Clear visibility of demand and payments is needed alongside a stable policy environment so that manufacturers can plan their investments. Our innovative financing tools help strengthen health markets so that more products are available for more people at affordable prices. #MarketShaping | #InnovativeFinance | #SustainableImpact

Sometimes, working in global health can feel a little abstract. We're often far away from the people we serve and the suppliers we partner with, and even the products we're trying to improve access to. I had a small insight into the latter earlier this month, when I attended the launch of SD Biosensor's new India Manufacturing Plant. It was great to see where and how these products are made before being sent to those who need them! MedAccess has partnered with SD Biosensor to boost access to Dual HIV-Syphilis tests for pregnant women, and deploy G6PD tests which ensure the correct treatment for malaria. https://lnkd.in/g8FwKP2a SD BIOSENSOR INC

📢 REMINDER: Our call for Expressions of Interest regarding near-point-of-care TB molecular diagnostics is open until 5 March 2025. We are exploring ways to support increased access to affordable #TB diagnostics in low- and middle-income countries. New diagnostics have the potential to bring TB services closer to the point of care and drive progress towards WHO’s #EndTB Strategy. We invite interested manufacturers to submit an expression of interest for financial tools (such as volume guarantees, debt financing, capital expenditure loans, or working capital) to improve access to near-point-of-care TB diagnostics. https://lnkd.in/eAh7ACeD

🆕 Two new publications in The Lancet Group Global Health this week have brought attention to an essential medicine access gap: oxygen. An estimated 25 million people die each year due to approximately 20 conditions requiring oxygen, such as pneumonia and heart disease. The two publications are: 1️⃣ Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security: https://lnkd.in/eJvxnB9c 2️⃣ The crucial role of industry in increasing access to medical oxygen. Co-authored by MedAccess' Kaodili Udeh, this commentary explores what's needed for oxygen production and distribution to be scaled up: https://lnkd.in/e5xNF5Au Doctors should not be forced to decide which patients to benefit from limited oxygen supplies. Access to Medicine Foundation | Clinton Health Access Initiative, Inc. | Oxygen Hub | The Global Fund | UNICEF | Unitaid

Exciting to see the UK and South Africa will co-host The Global Fund's Replenishment this year. 👏   The Global Fund's investment case outlines how a fully funded Global Fund could #Save23MillionLives and build stronger health systems. Together, we can accelerate access to products that prevent and treat HIV, TB and malaria and end the three deadliest infectious diseases.

We're looking forward to being part of the IFC Health #IFCHealthConference this week. MedAccess' Michael Anderson CB will share insights on a panel focused on the role of innovative finance in unlocking emerging market opportunities. Michael will speak about our volume guarantee and procurement guarantee products, and emphasise the power of partnerships in accelerating access to health products at scale. 📅 19 February 🕥 12:00 PM-12:45 PM 📍 Grand Ballroom For more information: https://lnkd.in/eT7J96e7

🤝 MedAccess is proud to be part of British International Investment's Catalyst portfolio. In December, our CEO Michael Anderson CB took part in an event to celebrate the portfolio's impact over the past decade and shared more about how MedAccess has helped more than 539 million people to access medical innovations. Listen back to Michael in the video, podcast and report below.

It was a pleasure to speak at #NCDAF2025, co-hosting a session with Novo Nordisk and IFPMA on unlocking innovative financing for NCDs.    At MedAccess, we've seen how financial solutions like volume guarantees can drive access and affordability in infectious diseases—now, the challenge is applying these models to NCDs despite funding and procurement barriers.    We recognize that our solutions must work within the realities of high reliance on domestic financing and out-of-pocket spending, and we remain committed to finding innovative ways to bridge these gaps. Looking forward to continued collaboration to expand access and impact! Kimberly Green Carissa Vados

🚨 Are you at #NCDAF2025 in Kigali this week? Join our co-hosted satellite session with Novo Nordisk and IFPMA tomorrow on: “Innovative financing: The power and potential to unlock more funding for NCDs in resource-constrained settings.” Mayank Anand, our Head of #NCDs and MNCH will speak about about potential roles for innovative financing to help tackle NCDs by incentivising and de-risking partners. 📅 14 February 🕥 10:30-11:45 📍 AD 12 For more information: https://lnkd.in/dqGhn6VC